IRCT20190212042693N1已完成3 期
: The effect of usage combination of Betadine 10%drop/ Levofloxacin drop the number of conjunctival bacterial colony culture preparation during cataract surgery
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 142
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50 years 至 no limit（—）
- 性别
- All
入选标准
- •Being scheduled for cataract surgery
- •not suffering from serious kidney diseases
- •not having infections in other body organs
- •aging above 50 years
- •not having consumed topical or systemic antibiotics over 10 days prior to the operation
- •and being willing to take part in the research.
排除标准
- •Suffering from diabetes disease
- •Rheumatoid Arthritis
- •having infection
研究者
相似试验
招募中
1 期
The Evaluation of effectiveness of betadine (Povidone-iodine) in one step and two step procedure in the treatment of patients with pleural effusion resistant to conventional treatments: a clinical trialResistant pleural effusion.IRCT20220117053750N1Kerman University of Medical Sciences40
招募中
不适用
The effect of betadine drop in neonatal conjunctivitiseonatal Conjunctivitis.Neonatal conjunctivitis and dacryocystitisIRCT2017022032680N1Qazvin University of Medical Sciences, Qazvin200
招募中
3 期
Comparison of the effect of adding pethidine to half-percent bupivacaine and half-percent ropivacaine on pain intensity in women undergoing elective cesarean sectioCesarean section.Onset (spontaneous) of labor after 37 completed weeks of gestation but before 39 completed weeks gestation, with delivery by (planned) cesarean sectionO75.82IRCT20210415050976N10Jahrom University of Medical Sciences60
招募中
1 期
Phase 1/2 study of the combination of Bendamustine and Rituximab for treatment of relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphomaJPRN-UMIN000005428Department of Hematology, International Medical Center, Saitama Medical University40
招募中
1 期
Phase 1/2 study of the combination of Bendamustine and Rituximab for treatment of elderly relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.JPRN-UMIN000006513Kinki University School of Medecine Division of Hematology43